Anders Helgeland

3.6k total citations · 1 hit paper
69 papers, 2.9k citations indexed

About

Anders Helgeland is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anders Helgeland has authored 69 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anders Helgeland's work include Blood Pressure and Hypertension Studies (12 papers), Hormonal Regulation and Hypertension (7 papers) and Computer Graphics and Visualization Techniques (5 papers). Anders Helgeland is often cited by papers focused on Blood Pressure and Hypertension Studies (12 papers), Hormonal Regulation and Hypertension (7 papers) and Computer Graphics and Visualization Techniques (5 papers). Anders Helgeland collaborates with scholars based in Norway, United States and United Kingdom. Anders Helgeland's co-authors include Paul Leren, Ingvar Hjermann, Ingar Holme, Per G. Lund‐Larsen, Sven Chr. Enger, Ivar Eide, Sverre E. Kjeldsen, Olav Foss, Øyvind Andreassen and Lars Aage Solberg and has published in prestigious journals such as The Lancet, American Journal of Epidemiology and The American Journal of Medicine.

In The Last Decade

Anders Helgeland

68 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of mild hypertension: A five year controlled drug trial

1980 506 citations Anders Helgeland profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Helgeland Norway	29	1.3k	846	580	405	402	69	2.9k
H. Mitchell Perry United States	33	1.0k 0.8×	862 1.0×	270 0.5×	261 0.6×	535 1.3×	104	3.9k
P S Sever United Kingdom	25	1.7k 1.3×	559 0.7×	453 0.8×	318 0.8×	335 0.8×	67	2.8k
Albert Oberman United States	31	1.4k 1.1×	511 0.6×	363 0.6×	562 1.4×	459 1.1×	73	2.6k
Clive Rosendorff United States	29	1.8k 1.4×	625 0.7×	520 0.9×	209 0.5×	734 1.8×	167	3.9k
L. Hansson Sweden	27	2.1k 1.6×	738 0.9×	367 0.6×	215 0.5×	223 0.6×	82	3.2k
Kimberley A. Eberlein United States	7	2.8k 2.2×	885 1.0×	506 0.9×	561 1.4×	272 0.7×	7	4.0k
N. Poulter United Kingdom	18	2.2k 1.7×	709 0.8×	505 0.9×	433 1.1×	186 0.5×	57	3.3k
John Webster United Kingdom	25	1.8k 1.4×	503 0.6×	422 0.7×	176 0.4×	337 0.8×	63	3.0k
Marion R. Wofford United States	22	1.3k 1.0×	858 1.0×	356 0.6×	314 0.8×	503 1.3×	37	3.3k
Lennart Hansson Sweden	22	2.4k 1.8×	909 1.1×	406 0.7×	186 0.5×	273 0.7×	70	3.2k

Countries citing papers authored by Anders Helgeland

Since Specialization

Citations

This map shows the geographic impact of Anders Helgeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Helgeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Helgeland more than expected).

Fields of papers citing papers by Anders Helgeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Helgeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Helgeland. The network helps show where Anders Helgeland may publish in the future.

Co-authorship network of co-authors of Anders Helgeland

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Helgeland. A scholar is included among the top collaborators of Anders Helgeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Helgeland. Anders Helgeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Helgeland, Anders, et al.. (2025). Blob velocities and sizes in the Alcator C-Mod scrape-off layer for ohmic and high confinement mode plasmas. Nuclear Materials and Energy. 43. 101930–101930. 1 indexed citations

Helgeland, Anders, et al.. (2024). A three-point velocity estimation method for two-dimensional coarse-grained imaging data. AIP Advances. 14(9). 4 indexed citations

Helgeland, Anders, Kent‐André Mardal, Victor M. Haughton, & Bjørn Anders Pettersson Reif. (2014). Numerical simulations of the pulsating flow of cerebrospinal fluid flow in the cervical spinal canal of a Chiari patient. Journal of Biomechanics. 47(5). 1082–1090. 27 indexed citations

Linge, Svein, Kent‐André Mardal, Victor M. Haughton, & Anders Helgeland. (2012). Simulating CSF Flow Dynamics in the Normal and the Chiari I Subarachnoid Space during Rest and Exertion. American Journal of Neuroradiology. 34(1). 41–45. 14 indexed citations

Linge, Svein, et al.. (2011). Effect of Tonsillar Herniation on Cyclic CSF Flow Studied with Computational Flow Analysis. American Journal of Neuroradiology. 32(8). 1474–1481. 32 indexed citations

Helgeland, Anders, et al.. (2007). Visualization of Vorticity and Vortices in Wall-Bounded Turbulent Flows. IEEE Transactions on Visualization and Computer Graphics. 13(5). 1055–1067. 9 indexed citations

Helgeland, Anders & Thomas Elboth. (2006). High-Quality and Interactive Animations of 3D Time-Varying Vector Fields. IEEE Transactions on Visualization and Computer Graphics. 12(6). 1535–1546. 16 indexed citations

Helgeland, Anders, et al.. (2004). Visualization of the energy-containing turbulent scales. 103–109. 3 indexed citations

Nafstad, Inger, et al.. (1988). The influence of atenolol and prazosin on serum lipids and atherosclerosis in minipigs fed a hyperlipidemic diet. General Pharmacology The Vascular System. 19(5). 719–724. 1 indexed citations

10.

Holme, Ingar, et al.. (1988). CORRELATES OF BLOOD PRESSURE CHANGE IN MIDDLE-AGED MALE MILD HYPERTENSIVES: RESULTS FROM THE UNTREATED CONTROL GROUP IN THE OSLO HYPERTENSION TRIAL. American Journal of Epidemiology. 127(4). 742–752. 10 indexed citations

11.

Helgeland, Anders & Paul Leren. (1987). Oslo Study: Treatment of Mild Hypertension. The Nephron journals/Nephron journals. 47(1). 108–110. 7 indexed citations

12.

Baksaas, Ingebjørg, et al.. (1986). [Hypertension and type II diabetes. Therapeutic attitudes among Norwegian physicians. A questionnaire study].. PubMed. 106(25). 2018–22. 1 indexed citations

13.

Holme, Ingar, Anders Helgeland, Ingvar Hjermann, Paul Leren, & Per G. Lund‐Larsen. (1981). Physical Activity at Work and at Leisure in Relation to Coronary Risk Factors and Social Class. Acta Medica Scandinavica. 209(1-6). 277–283. 81 indexed citations

14.

Kjeldsen, Sverre E., et al.. (1981). Increased Peripheral Release of Noradrenaline and Uptake of Adrenaline in Essential Hypertension?. Clinical Science. 61(s7). 215s–217s. 23 indexed citations

15.

Holme, Ingar, Anders Helgeland, Ingvar Hjermann, Paul Leren, & Per G. Lund‐Larsen. (1980). Four-year mortality by some socioeconomic indicators: the Oslo study.. Journal of Epidemiology & Community Health. 34(1). 48–52. 86 indexed citations

16.

Fauchald, Per, et al.. (1978). [Treatment of high blood pressure with prazosin (Peripress). An open study by 123 general physicians and 24 specialists in internal medicine].. PubMed. 98(30). 1494–9. 1 indexed citations

17.

Helgeland, Anders, Ingvar Hjermann, Paul Leren, Sven Chr. Enger, & Ingar Holme. (1978). High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.. BMJ. 2(6134). 403–403. 114 indexed citations

18.

Helgeland, Anders, Ingvar Hjermann, Paul Leren, & Ingar Holme. (1978). Possible metabolic side effects of beta-adrenergic blocking drugs.. BMJ. 1(6116). 828–828. 39 indexed citations

19.

Helgeland, Anders, et al.. (1977). [Coronary risk factors and socioeconomic status. The Oslo study].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 97(27). 1380–2. 3 indexed citations

20.

Holme, Ingar, Anders Helgeland, Ingvar Hjermann, Paul Leren, & Per G. Lund‐Larsen. (1977). Coronary risk factors in various occupational groups: the Oslo study.. Journal of Epidemiology & Community Health. 31(2). 96–100. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact